Q1 2026 Holdings
Filed 2026-05-15 | 120 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Geron Corp(GERN) | COM | 374163103 | $28.1M | 18,834,883 | 1.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $28.9M | 3,039,820 | 1.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $30.1M | 143,546 | 1.6% |
| Healthpeak Properties Inc(DOC) | COM | 42250P103 | $32.5M | 1,981,070 | 1.7% |
| Welltower Inc(WELL) | COM | 95040Q104 | $35.8M | 180,953 | 1.9% |
| Ishares TR(TLT)Put | 20 YR TR BD ETF | 464287432 | $37.2M | 428,800 | 2.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $37.5M | 79,229 | 2.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $40.2M | 90,000 | 2.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $47.5M | 632,100 | 2.5% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $48.8M | 3,568,555 | 2.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $53.7M | 924,193 | 2.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $56.7M | 1,788,016 | 3.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $67.4M | 2,885,622 | 3.6% |
| State STR Spdr S&P 500 ETF T(SPY)Put | TR UNIT | 78462F103 | $69.6M | 107,000 | 3.7% |
| Natera Inc(NTRA) | COM | 632307104 | $76.9M | 384,713 | 4.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $87.4M | 2,173,286 | 4.6% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $98.5M | 1,785,175 | 5.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $104.0M | 934,423 | 5.5% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $137.8M | 238,700 | 7.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $156.7M | 264,271 | 8.3% |